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Abstract
Early detection of lesions while minimising the unnecessary removal of benign lesions is the clinical
aim in melanoma diagnosis. In this context, several non-invasive diagnostic modalities, such as
dermoscopy, total body photography, and reflectance confocal microscopy have emerged in recent
years aiming at increasing diagnostic accuracy. The main developments in this field are the integration
of dermoscopy and digital photography into clinical practice.
Introduction and context
Successful treatment of melanoma, by surgical removal, is
reliant onthe earlydetectionofthe lesion.The challengeis
to diagnose and remove all malignant lesions at an early
stagewhileminimisingtheunnecessaryremovalofbenign
lesions. Visual inspection with the naked eye has a
relatively low sensitivity in detecting early melanoma
[1-3]. In this context, several non-invasive diagnostic
modalities, such as dermoscopy, total body photography,
andreflectanceconfocalmicroscopy(RCM),haveemerged
in recent years that are aimed at increasing diagnostic
accuracy and raising the threshold for surgical procedures.
Recent advances
Dermoscopy
Dermoscopy (also known as dermatoscopy or epilumi-
nescence microscopy) allows for the visualization of
anatomical structures within the epidermis and papillary
dermis that would otherwise not be able to be visualised
by the naked eye [4]. This is achieved with the use of a
hand held dermatoscope to magnify the skin surface and
reduce the refraction of light by the corneal layer. Various
diagnostic algorithms (pattern analysis, ABCD rule,
Menzies method, seven-point checklist, and three-point
check list) have been proposed to help assess the
structures and patterns seen in dermoscopy. Recently,
criteria for amelanotic/hypomelanotic melanoma have
been described (Table 1).
There are two different types of dermatoscopes: the
original, non-polarised version requires an immersion
medium (oil, alcohol) and is superior in visualising
blue-white areas (often associated with regression),
milia-like cysts, and comedo-like openings (features of
seborrheic keratosis). The alternative dermatoscope uses
polarised light and has been found to be better for
assessing vascular structures and shiny white streaks that
could be a sign of fibrosis [5]. It has been proposed that
using the two different dermatoscopes in conjunction
with each other may help to increase the sensitivity and
specificity of detecting melanoma [6].
Various studies and three meta-analyses of the literature
have validated the ability of dermoscopy to increase
diagnostic accuracy. Dermoscopy was shown to be
superior to naked-eye examination performed by spe-
cialists in two meta-analyses [1,3]. Recently, a meta-
analysis by Vestergaard et al.[ 2 ] ,w h i c hf o c u s e d
exclusively on trials that were performed in a clinical
setting, found that the relative diagnostic odds ratio was
15.6 for the use of dermoscopy to diagnose melanoma
compared with naked-eye examination.
Furthermore, it has been reported that dermoscopic
training for primary care physicians can improve their
ability to correctly refer individuals with suspicious
lesions and decrease the rate of excision or referral in
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with the aid of dermoscopy requires less than 3 minutes
[10]. Haenssle and colleagues [11] performed a pro-
spective long-term study with patients at high risk for
melanoma in a real-life clinical setting using the seven-
point checklist to dermoscopically score melanocytic
lesions. A sensitivity of 62% for lesions scoring more
than 3 points and specificity of 97% was found. Of the
melanomas that were false negatives on dermoscopic
evaluation, 25% were detected by dermoscopic follow-
up and 13% by complementary patient history and the
‘ugly duckling’ sign. Regression pattern, radial streaming,
and atypical vascular pattern were found to be the criteria
associated with the highest relative risk for melanoma.
Overall, there is strong scientific evidence that clinical
examination, including detailed anamnesis for identify-
ing melanoma risk factors (family and personal history
of melanoma, total number of nevi, including number of
atypical nevi, skin type, presence of ephelides, hair and
eye colour, non-melanoma skin cancer history, history of
intermittent sun exposure) [12], and full body clinical
inspection with detection of any lesions that are
dissimilar to the rest (‘ugly ducklings’ [13]) aided by
dermoscopy, is the gold-standard in non-invasive
diagnosis of melanoma.
Total body photography and sequential dermoscopic
follow-up
Photography enables documentation of lesions and
has the ability to track and compare any changes over
time. Macroscopic digital pictures of standardised body
positions and digital dermoscopic images of lesions of
concern enable nearly the entire body surface to be
r e c o r d e da n dr e f e r r e dt oi nf ollow-up examinations.
This technique is particularly helpful in the surveil-
lance of individuals with numerous nevi with a family
history of melanoma (so-called dysplastic nevus
syndrome). Photographic monitoring aids in identify-
ing stable lesions and early detection of any concerning
changes [14]. Theoretically, any photographic equip-
ment can be used for total body photography but there
are now specific digital skin photography systems
available.
Technologic advances have led to the development of
devices for sequential digital dermoscopy. Digital
dermoscopic (and clinical) images are taken and linked
to the body site via a computer. At follow-up visits
the same lesion is re-photographed for comparison.
This method has helped to detect a subgroup of slow-
growing melanomas that lack suspicious features at
baseline examination but exhibit detectable changes on
follow-up [15].
However, due to the increased time expenditure and cost
of follow-up for every melanocytic lesion in a given
patient, there is a need to correctly identify those that
benefit most from digital dermoscopic follow-up.
Haenssle et al. [16] performed a prospective long-term
study including patients at risk for development of
melanoma to identify those who benefit most from
sequential dermoscopy follow-up. According to the
results,theauthorssuggestedafollow-upplanasfollows:
(a) short-term follow-up of 3 months for patients with
familial atypical mole and melanoma syndrome and (b)
long-term follow-up of 6-12 months for those with
atypicalmole syndrome.Patients withmultiplecommon
nevi and no additional risk factors were found to have
low benefit from sequential digital dermoscopy.
Table 1. Melanoma features in dermoscopy
Menzies method [38] 7-point checklist [39] Amelanotic and hypomelanotic melanoma [40]
Positive features Major criteria Positive features
1. Blue-white veil Score: +2 1. Irregularly sized or distributed brown dots/globules
2. Multiple brown dots 1. Atypical pigment network 2. Multiple blue/gray dots
3. Pseudopods 2. Blue-whitish veil 3. Irregularly shaped depigmentation
4. Radial streaming 3. Atypical vascular pattern 4. Blue-white veil
5. Scar-like depigmentation 5. More than one shade of pink
6. Peripheral black dots/globules Minor criteria 6. Predominant central vessels
7. Multiple colors Score: +1 7. Dotted and linear irregular vessels







1. More than three milia-like cysts
1. Symmetry of pattern
2. Presence of a single color
Absence of negative features and presence of ≥1
positive feature is diagnostic of melanoma
Score ≥3 is diagnostic of melanoma Absence of negative features and presence of ≥1
positive feature is diagnostic of melanoma
For more details on dermoscopic diagnosis, including ABCD rule and pattern analysis, see [41].
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include the potential for loss to follow-up [17]. Only
preselected lesions are dermoscopically monitored and
changes in a previously unsuspicious lesion or a de novo
lesion might therefore be missed. Of note, suspicious
nodular lesions should be excised immediately rather
than observed over time as they are at higher risk of rapid
change and spread if malignant.
The use of digital imaging has the added benefit of
enabling teledermatologic applications. Teledermoscopy
is defined as the transmission of digital dermoscopic
images over a distance for specialist consultation,
allowing primary care physicians to forward dermo-
scopic images to dermatologists for second opinion [18].
Good interobserver agreement between face-to-face
diagnosis and diagnosis based on digital images has
been demonstrated in several studies [19]. Furthermore,
digital dermoscopic and clinical still images with
complementary clinical data have been shown to
increase confidence and interobserver agreement [20].
The feasibility of teledermoscopy using mobile devices
has been recently demonstrated, highlighting the poten-
tial of mobile teledermoscopy as a screening and triage
tool [21]. Teledermoscopy is particularly useful in
remote areas where referral to a specialist is financially
demanding and time consuming for the patient.
Reflectance confocal microscopy
RCM is a non-invasive imaging technique that uses a
near infrared laser beam to create black and white images
in a horizontal plane. The images are able to define
cellular structures and morphology and can obtain
images, with good resolution, of the epidermis, dermoe-
pidermal junction, and the superficial dermis. RCM
images are created from the difference in reflectivity of
different tissue structures. Melanin and melanosomes are
strongly reflective, making RCM a suitable modality for
examining melanocytic lesions [22].
Several recent studies have identified RCM features of
melanoma and nevi and have found key differences
between the two. In short, features most suggestive of
melanoma as found by Pellacani et al. [23,24] are
displayed in Table 2. Other diagnostic algorithms for
melanoma diagnosis have been proposed [25-27].
Gerger and colleagues [26] developed a decision tree
analysis based on three RCM features (monomorphic
melanocytic cells, keratinocyte borders, and poly-
morphic melanocytic cells). Segura and colleagues
[27] recently presented a two-step algorithm for
differentiation between melanocytic lesions and non-
melanocytic lesions in the first step and between nevi
and melanoma in the second step. A recent focus of
interest is the value of RCM in diagnosis and pre-
operative mapping of surgical margins in lentigo
maligna (melanoma in situ in severely sun-damaged
skin) [28,29]. A recently developed algorithm for
diagnosis of lentigo maligna of the face is displayed
in Table 2. Furthermore, a glossary of commonly used
RCM terms has been published [30]. RCM is a
promising potential clinical tool; however, large-scale
clinical studies are required to be able to determine the
entirety of its benefit.
Other non-invasive diagnostic tools
Other non-invasive diagnostic techniques currently in
the process of being developed include multispectral
image analysis, multiphoton laser scanning microscopy
(MPM), optical coherence tomography, high frequency
ultrasound, computer-assisted diagnosis, and molecular
profiling.
Table 2. Features of melanoma in reflectance confocal microscopy (RCM)
Features of melanoma in RCM Features of facial lentigo maligna in RCM
2 major criteria 2 major criteria
Score: +2 Score: +2
1. Cell atypia at the DEJ 1. Round large pagetoid cells >20 µm
2. Non-edged papillae 2. Non-edged papillae
4 minor criteria 4 minor criteria
Score: +1 Positive features, Score: +1
1. Roundish pagetoid cells 1. Three or more atypical cells at the DEJ in five fields of 500 × 500 µm
2. Widespread pagetoid infiltration 2. Follicular localization of atypical cells
3. Cerebriform nests 3. Nucleated cells within dermal papillae
4. Nucleated cells within dermal papillae Negative feature, Score: -1
4. Broadened honeycomb pattern in epidermis
Score ≥3 diagnostic for melanoma (sensitivity 97%; specificity 72%) Score ≥2 diagnostic for lentigo maligna (sensivity 85%; specifity 76%)
The algorithm for melanoma diagnosis displayed above has been described by Pellacani et al. [42] and features of facial lentigo maligna have been described by
Guitera et al. [29]. DEJ, dermal-epidermal junction.
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different wavelengths of light penetrate the skin to
different depths, enabling computer-aided visualization
of criteria invisible to macroscopic and dermoscopic
techniques.
High frequency ultrasound provides limited resolution
images of the skin in the vertical plane. When used alone
it is not reliable for diagnostic purposes. It can be used,
however, as a tool for assessing tumour thickness and
vascularity, which can assist in planning management
preoperatively [31].
Optical coherence tomography is comparable to ultra-
sound but uses light instead of sound waves; it reaches a
lower depth, providing a better resolution than ultra-
sound, but does not reach the resolution capabilities of
RCM. Although there are studies regarding the various
features of skin cancer, reports of diagnostic accuracy are
lacking [32].
MPM utilizes non-linear excitation by a near-infrared
laser source. Like RCM, the MPM allows imaging of
horizontal sections of the skin, allowing visualization of
cellular and subcellular structures. To date it is mainly
used as a research tool [33].
Computer-assisted diagnosis uses automated diagnostic
systems that extract and analyse criteria of skin lesions
to provide a diagnosis without subjective human inter-
pretation bias. It has been shown to reach levels of
diagnostic accuracy similar to that of expert dermatolo-
gists [34,35]. However, in order not to miss a melanoma,
there is a tendency for these tools to overdiagnose
melanoma. A recent meta-analysis showed a slightly
higher sensitivity for computer-aided dermoscopic diag-
nosis compared to expert diagnosis, but significantly
lower specificity [36]. To date, a few fully automated
systems are available, some of which are integrated in the
software of videodermoscopy devices. MelaFind® uses
multispectral imaging and the DB-MIPS system extracts
information from dermoscopic images. The MelaFind
system is currently in the final stages of being granted US
Food and Drug Administration approval.
Molecular profiling for the diagnosis of melanoma is an
emerging development. A method that uses RNA
acquired from the cornified layer of a lesion gathered
by tape stripping [37] is currently being investigated.
Implications for clinical practice
To date, the current standard method for melanoma
diagnosis is naked-eye inspection with closer dermo-
scopic examination of suspicious lesions to determine
which should be excised and sent for histopathological
confirmation. The use of digital photography to track
changes has been shown to be effective and is now
integrated into practice. It is difficult to predict how
clinical practice will be affected and if the new emerging
imaging modalities, such as RCM, MPM, and computer-
assisteddiagnosis,willprevail,orifmolecularanalysiswill
substitute morphology. Further large-scale studies will
determine their importance. Despite emerging technolo-
gies, it remains crucial to evaluate lesions in the context of
the examination of the individual patient. Only those
lesions that are considered suspicious can be further
evaluated due to time expenditure, and, therefore, careful
clinicalexaminationandpre-selectionisstillirreplaceable.
Abbreviations
MPM, multiphoton microscopy; RCM, reflectance con-
focal microscopy.
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